Phase 2 Breast Cancer Trial, Not Yet Recruiting NCT05979220 Sponsor: Shuangyue Liu Condition: Breast Cancer
Back to Breast Cancer

Phase 2 Breast Cancer Trial, Not Yet Recruiting

NCT05979220
Not Yet Recruiting Phase 2

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed by a pathologist (lab tissue testing) with breast cancer that has come back in the same area or spread to other parts of the body, and whose cancer is hormone-receptor positive and HER2 negative.
  • People aged between 18 and 75 years old.
  • People who are either fully active or have only minor limitations in daily physical activity (as measured by a standard medical scale called ECOG, scored 0 or 1).
  • People whose liver and kidney are functioning normally.
  • People who have agreed to use contraception throughout the treatment period.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose cancer has been confirmed as HER2 positive.
  • People whose cancer has spread to the central nervous system (the brain or spinal cord).
  • People who have previously been treated with a type of drug called a CDK4/6 inhibitor.
  • People who have significant heart or blood vessel conditions, including a severe heart attack in the past 6 months, unstable or severe chest pain, moderate-to-severe heart failure, or a serious irregular heartbeat that requires medical treatment.
  • People whom the trial researchers consider unsuitable for the study for any other reason (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026

Contact this trial

Phone: 18602866299

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 2
Sponsor
Shuangyue Liu
Registry
ClinicalTrials.gov
Start date
1 December 2023
Est. completion
30 June 2024

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Progression Free Survival (PFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov